NCT04449692View on ClinicalTrials.gov

Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 2, 2020

Primary Completion Date

January 4, 2021

Study Completion Date

January 4, 2021

Conditions
Type 1 DiabetesHypoglycemia
Interventions
DRUG

Dasiglucagon

Abdominal s.c. administration

OTHER

Carbohydrate (dextrose tablets)

Oral administration

Trial Locations (1)

2820

Steno Diabetes Center Copenhagen, Gentofte Municipality

All Listed Sponsors
lead

Steno Diabetes Center Copenhagen

OTHER

NCT04449692 - Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes | Biotech Hunter | Biotech Hunter